The ACS's mission-driven venture capital fund
BrightEdge exists to accelerate the American Cancer Society's mission for a world without cancer.
About
We invest in the development of life-saving therapeutics
BrightEdge invests in the most promising for-profit oncology companies bringing innovative treatments to market.
Portfolio
Fighting for a World Without Cancer
BrightEdge is led by a world-class team of investors, operators, and entrepreneurs to ensure the best cancer innovations are brought to market.
Team